CA2790682C - Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds - Google Patents

Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds Download PDF

Info

Publication number
CA2790682C
CA2790682C CA2790682A CA2790682A CA2790682C CA 2790682 C CA2790682 C CA 2790682C CA 2790682 A CA2790682 A CA 2790682A CA 2790682 A CA2790682 A CA 2790682A CA 2790682 C CA2790682 C CA 2790682C
Authority
CA
Canada
Prior art keywords
skin
weight
antimicrobial peptide
composition
zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2790682A
Other languages
English (en)
French (fr)
Other versions
CA2790682A1 (en
Inventor
Frank Dreher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anteis SA
Original Assignee
Anteis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anteis SA filed Critical Anteis SA
Publication of CA2790682A1 publication Critical patent/CA2790682A1/en
Application granted granted Critical
Publication of CA2790682C publication Critical patent/CA2790682C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA2790682A 2010-03-03 2011-03-02 Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds Active CA2790682C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31016810P 2010-03-03 2010-03-03
US61/310,168 2010-03-03
PCT/US2011/026804 WO2011109469A1 (en) 2010-03-03 2011-03-02 Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds

Publications (2)

Publication Number Publication Date
CA2790682A1 CA2790682A1 (en) 2011-09-09
CA2790682C true CA2790682C (en) 2020-11-24

Family

ID=43805714

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2790682A Active CA2790682C (en) 2010-03-03 2011-03-02 Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds

Country Status (7)

Country Link
US (1) US9629856B2 (https=)
EP (1) EP2542246A1 (https=)
JP (1) JP2013521300A (https=)
KR (1) KR20130018739A (https=)
CN (1) CN102985091B (https=)
CA (1) CA2790682C (https=)
WO (1) WO2011109469A1 (https=)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2498603B1 (en) * 2009-11-12 2016-07-13 Signum Biosciences, Inc. Use of anti-bacterial agents for the treatment of epithelial-related conditions
CA2790682C (en) 2010-03-03 2020-11-24 Neocutis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
CA2810746A1 (en) * 2010-06-30 2012-01-05 Galderma Research & Development Method for preventing or treating skin tumor
US8236288B2 (en) * 2011-01-07 2012-08-07 Skinmedica, Inc. Melanin modification compositions and methods of use
AU2012275292B2 (en) 2011-06-28 2015-11-12 Chemo Research, S.L. High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis
FR2984126B1 (fr) * 2011-12-20 2014-08-22 Oreal Polysaccharides sulfates agent antipelliculaire
CN102614298B (zh) * 2012-04-26 2013-10-30 肖连元 一种烫伤喷剂及其制备方法
DE102012214038A1 (de) * 2012-08-08 2014-02-13 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus Harnstoff und Car-ni-tin und/oder einem oder mehreren Acyl-Carnitinen zur Behandlung und Prophylaxe von Neurodermitis sowie des diabetischen Fußes
GEAP201913925A (en) * 2013-01-30 2019-07-10 Boris Gorinshteyn Compositions and methods for treating surface wounds
WO2014124458A1 (en) * 2013-02-11 2014-08-14 The Regents Of The University Of California Compositions and methods for treating neurodegenerative diseases
FR3002452B1 (fr) * 2013-02-28 2016-02-12 Dermaconcept Jmc Composition dermatologique antimicrobienne topique
GB201304041D0 (en) * 2013-03-06 2013-04-17 Water Jel Europ Llp Treatment and prophylaxis of radiation dermatitis
WO2014140890A2 (en) 2013-03-13 2014-09-18 Neocutis Sa Peptides for skin rejuvenation and methods of using the same
CN103263476B (zh) * 2013-05-30 2015-05-13 广州市绿乔生物科技有限公司 一种用于减少刺激的复合抑菌剂
US9193852B2 (en) * 2013-12-27 2015-11-24 L'oreal Stable aerated compositions
CN104138397A (zh) * 2014-01-13 2014-11-12 北京德默高科医药技术有限公司 一种预防和辅助治疗痔疮的组合物
ES2919024T3 (es) 2014-02-11 2022-07-21 Mitokinin Inc Composiciones y procedimientos que utilizan las mismas para el tratamiento de enfermedades neurodegenerativas y mitocondriales
CN103816089A (zh) * 2014-03-11 2014-05-28 广州市洋林生物科技开发有限公司 一种皮肤粘膜抗菌液及皮肤粘膜抗菌湿巾
CN103830303B (zh) * 2014-03-11 2016-03-02 北京德默高科医药技术有限公司 一种预防褥疮的组合物
CN116515924A (zh) * 2014-04-16 2023-08-01 青岛惠诺德生物科技有限公司 一种生物活性透明质酸片段、其生产方法、应用、制剂及含有该制剂的物品
FR3020570B1 (fr) * 2014-04-30 2017-07-21 Pierre Fabre Dermo Cosmetique Association d'un acide hyaluronique et d'un polysaccharide sulfate
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
US10912811B1 (en) * 2014-10-28 2021-02-09 Felician Stancioiu Composition for improving peripheral circulation and healing of hematomas
WO2016090494A1 (en) * 2014-12-12 2016-06-16 Oceans Ltd. Anti-microbial seaweed extracts, compositions and uses thereof
GB2536072A (en) * 2014-12-13 2016-09-07 Berezin Anatoljevieh Vadim Method for determination of the choice of the active ingredients of biological and chemical composition against infectious, oncology, skin diseases, which are
WO2016137513A1 (en) * 2015-02-27 2016-09-01 Sutich Paul Method and topical composition for the treatment of rosacea and skin erythema using selenium sulfide
CN104761629B (zh) * 2015-03-05 2017-12-26 大连理工大学 一种广谱高效抗微生物肽Pb‑CATH‑OH1及其基因、制备方法和应用
KR101721228B1 (ko) * 2015-04-03 2017-03-30 사회복지법인 삼성생명공익재단 지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물
CN104721129A (zh) * 2015-04-13 2015-06-24 上海东晟源日化有限公司 微乳化生物科技护肤品
CN106267168A (zh) * 2015-05-12 2017-01-04 浙江海汇医疗科技有限公司 一种哺乳期妇女用乳头皲裂贴
CN104928081B (zh) * 2015-05-26 2018-01-16 广州瑞嘉精细化工有限公司 一种抑螨除螨的马油和植物组合物及其在制皂中的用途
CN105254736B (zh) * 2015-09-02 2018-06-08 大连理工大学 源于缅甸蟒的cathelicidin家族广谱抗微生物肽Pb-CATH4及其基因、制备与应用
CN105085647B (zh) * 2015-09-07 2018-06-08 大连理工大学 天然抗感染抗氧化双功能肽Pb-CATH2及其基因与应用
US11702523B2 (en) 2015-09-09 2023-07-18 Bloom Holdings, Llc Algae-derived flexible foam, and method of manufacturing the same
KR102463131B1 (ko) * 2015-09-30 2022-11-04 (주)아모레퍼시픽 Aha, 우레아, 및 니아신아마이드를 포함하는 각질 연화용 및 미백용 화장료 조성물
CN105287629B (zh) * 2015-10-23 2018-04-17 四川农业大学 一种动物脱毛治疗剂的制备方法及其药用用途
EP3380549A4 (en) 2015-11-19 2019-09-11 Bloom Holdings, LLC SOFT FLEXIBLE FOAM DERIVED FROM ALGAE AND METHOD FOR THE PRODUCTION THEREOF
WO2017105413A1 (en) 2015-12-15 2017-06-22 Medicell Technologies, Llc Stem cell stimulating compositions and methods of treating melasma
ITUB20160058A1 (it) * 2016-01-19 2017-07-19 Farm S R L C U S Composizione di un preparato per il trattamento delle punture di insetto con attivita’ vasocostrittiva, lenitiva, disinfiammante e disarrossante
CN105622720B (zh) * 2016-02-23 2020-09-08 浙江海洋学院 一种激活Nrf2-ARE通路的双髻鲨鱼肉抗氧化肽
CN106075334A (zh) * 2016-06-23 2016-11-09 贝亲管理（上海）有限公司 一种组合物在辅助治疗婴儿湿疹中的用途
US11103544B2 (en) 2016-12-30 2021-08-31 Ann And Robert H. Lurie Children's Hospital Of Chicago Application of honey and bacteria in methods of treating scalp conditions and hair conditions
US12337019B2 (en) 2016-12-30 2025-06-24 Northwestern University Vehicles for applying bacteria to skin, scalp, and hair
CN108633253A (zh) * 2017-01-19 2018-10-09 崔性铉 包括特应性疾病的血浆蛋白质的渗出性皮肤疾病的缓解及治疗用衬垫
JP6900067B2 (ja) * 2017-02-07 2021-07-07 オンコクロス カンパニー，リミテッド 癌の転移抑制および治療用組成物
KR101859922B1 (ko) * 2017-02-07 2018-05-21 주식회사 온코크로스 클로페네신을 포함하는 대장암 증식 및 전이 억제용 조성물
CN106860401A (zh) * 2017-02-09 2017-06-20 林映津 一种纯天然伤口修复剂
CN106943594A (zh) * 2017-03-29 2017-07-14 西安交通大学 Psoriasin抗体和LL‑37抗体在制备防治银屑病的药物中的应用
EA039464B1 (ru) * 2017-04-26 2022-01-31 Др. Редди'З Лабораториз Лимитед Композиции для местного применения для ухода за кожей
AU2018290225A1 (en) 2017-06-21 2020-01-23 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
KR101983668B1 (ko) * 2017-08-22 2019-05-29 건국대학교 산학협력단 그람 음성 박테리아에 대한 강한 항균 활성을 갖는 벌거숭이두더지쥐 유래의 항균성 폴리펩티드 및 이를 포함하는 약학 조성물
MY210233A (en) * 2017-10-11 2025-09-04 Illustris Pharmaceuticals Inc Methods and compositions for topical delivery
AU2018385766B2 (en) 2017-12-15 2022-12-01 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
WO2019144116A1 (en) 2018-01-22 2019-07-25 Cancer Commons Platforms for conducting virtual trials
WO2019167934A1 (ja) * 2018-02-28 2019-09-06 三生医薬株式会社 皮膜組成物及び該皮膜組成物を用いたカプセル剤
EP3765057A4 (en) * 2018-03-13 2022-01-05 Peptilogics, Inc. TREATMENT OF IMPLANTS WITH GENERALLY MODIFIED AMPHIPHILIC PEPTIDES
CN108324926B (zh) * 2018-03-23 2021-12-28 高志涛 干细胞提取物和抗菌肽的组合物及其用途
CN108403582A (zh) * 2018-04-08 2018-08-17 北京皓尔生物科技有限公司 一种含抗菌肽的防痘、祛痘组合物及其应用
CN108294997A (zh) * 2018-04-09 2018-07-20 青岛溯博生物技术有限公司 天然物质复合抗菌面膜粉、面膜及制备方法
WO2019204729A1 (en) * 2018-04-19 2019-10-24 Worcester Polytechnic Institute Compositions and methods for skin treatments
IT201800005585A1 (it) * 2018-05-22 2019-11-22 Composti per prevenire e trattare affezioni della pelle o della mucosa con componente infiammatoria
CA3117657A1 (en) * 2018-11-27 2020-06-04 Colgate-Palmolive Company Multi-benefit personal care compositions and methods for the same
CA3125456A1 (en) * 2019-01-04 2020-07-09 Dermata Therapeutics, Llc Compositions and methods for the treatment of skin conditions
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
FR3094637A1 (fr) * 2019-04-04 2020-10-09 Pierre Fabre Dermo-Cosmetique Sulfate de dextran dans les dermatoses inflammatoires
CN109916917B (zh) * 2019-04-17 2021-07-13 湖北三环锻造有限公司 一种渗透探伤工艺
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
CN114867464A (zh) * 2019-08-06 2022-08-05 大自然化妆品股份有限公司 局部化妆品组合物、所述组合物和用于面部施用滋补剂的用途
MY206715A (en) * 2019-09-20 2025-01-03 Univ Fukui Pharmaceutical composition
EP4017470A1 (en) 2019-12-16 2022-06-29 Colgate-Palmolive Company Personal care compositions and methods for the same
MX2022007079A (es) 2019-12-16 2022-07-11 Colgate Palmolive Co Composiciones para el cuidado personal y metodos para estas.
CN111388740B (zh) * 2020-05-21 2021-09-10 南通大学 一种促伤口愈合敷料及其制备方法
KR102174084B1 (ko) * 2020-06-01 2020-11-04 바이오닉랩 주식회사 Afa 블루그린알지를 이용한 피부개선 및 피부재생용 화장품 조성물
DE102020211389A1 (de) 2020-09-10 2022-03-10 Beiersdorf Aktiengesellschaft Wirkstoffhaltige Wundverschlusszubereitung
CN112043817A (zh) * 2020-09-14 2020-12-08 北京皓尔生物科技有限公司 一种抗螨虫的组合物及其应用
KR20230048426A (ko) * 2020-09-29 2023-04-11 로레알 다양한 화장품층을 갖는 피부 상의 선스크린을 검출하기 위한 방법 및 장치
CN112220705B (zh) * 2020-10-29 2021-07-06 芭芭多芦荟生物科技研究(广州)院 纯天然组分的保湿化妆品
DE212020000280U1 (de) * 2020-11-10 2021-01-07 Nantong Youyuan art design Co.,Ltd. Kryokonservierungsrohr für mesenchymale Plazentastammzellen mit Überzugsschicht aus Ginsengpolysaccharid
CN112603993A (zh) * 2020-12-19 2021-04-06 江苏诺瓦立医疗用品有限公司 一种基于壳聚糖治疗炎性痤疮的凝胶及其制备方法
KR102744422B1 (ko) * 2021-03-08 2024-12-19 주식회사 엘지생활건강 카르니틴살리실레이트(ca-sa)를 유효성분으로 포함하는 화장료 조성물
CN113527428B (zh) * 2021-09-17 2021-12-21 渤海水产育苗(山东)有限公司 海参肽及其应用和产品
CN114209809B (zh) * 2021-12-24 2023-09-05 成都佩德生物医药有限公司 一种抗痤疮丙酸杆菌的联合用药物组合物及其应用
WO2023129413A1 (en) * 2021-12-31 2023-07-06 Ingredient Fusion, Llc Molecular complexing method, formulation and manufacturing for enhanced nutrient delivery
CA3249846A1 (en) 2022-01-28 2023-08-03 Kenvue Brands Llc Predictive Biomarkers for Atopic Dermatitis
KR20250025597A (ko) 2022-04-04 2025-02-24 존슨 앤드 존슨 컨수머 인코포레이티드 아토피성 피부염의 발병을 예방하거나 아토피성 피부염을 치료하기 위한 기회의 창 피부 치료 요법 및 조성물
US11730694B1 (en) 2022-05-25 2023-08-22 L'oreal Hair coloring compositions and methods
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof
CN115011659B (zh) * 2022-07-19 2024-04-19 北京臻味坊食品有限公司 混合坚果肽的制备方法和设备
US12201717B2 (en) 2022-10-31 2025-01-21 Skinfix Inc. Compositions and methods for supporting skin barrier homeostasis
WO2024102456A1 (en) * 2022-11-09 2024-05-16 Cfd Research Corporation Compositions and methods for controlled release of therapeutic agents from articles
CN117064811B (zh) * 2023-09-18 2024-04-12 广东省华桑丽皙生物技术有限公司 含有蚕丝抗菌肽的组合物及其在化妆品中的应用
WO2025174368A1 (en) * 2024-02-14 2025-08-21 Sonenblick Jaacov Dermatological cream formulated for skin affected by wearable electronics
CN118243829B (zh) * 2024-05-29 2024-08-30 南通大学附属医院 一种治疗腹泻的蒙脱石药物有效成分检测方法
WO2025261730A1 (en) * 2024-06-21 2025-12-26 Unilever Ip Holdings B.V. Use of starch for achieving antimicrobial efficacy

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US3238100A (en) 1963-07-23 1966-03-01 American Maize Prod Co Starch phosphate film composition and method of dressing wounds with same
JPS5677294A (en) * 1979-08-28 1981-06-25 Maruko Seiyaku Kk Aluminum compound substance of sucrose sulfate and dihydroxy aluminum allantoinate
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
US4509949A (en) 1983-06-13 1985-04-09 The B. F. Goodrich Company Water thickening agents consisting of copolymers of crosslinked acrylic acids and esters
GB8401206D0 (en) 1984-01-17 1984-02-22 Allied Colloids Ltd Polymers and aqueous solutions
GB8414950D0 (en) 1984-06-12 1984-07-18 Allied Colloids Ltd Cationic polyelectrolytes
GB8531118D0 (en) 1985-12-18 1986-01-29 Allied Colloids Ltd Copolymers
US4912093A (en) 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
GB8622797D0 (en) 1986-09-22 1986-10-29 Allied Colloids Ltd Polymeric particles
ES2061508T3 (es) 1986-10-01 1994-12-16 Allied Colloids Ltd Composiciones polimericas solubles en agua.
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
DK505488D0 (da) 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5916880A (en) * 1987-12-21 1999-06-29 Bukh Meditec A/S Reduction of skin wrinkling using sulphated sugars
GB8909095D0 (en) 1989-04-21 1989-06-07 Allied Colloids Ltd Thickened aqueous compositions
DE3922170A1 (de) * 1989-07-06 1991-01-10 Giulini Chemie Neue salze von poly(alkylvinylether-maleinsaeureanhydrid) und damit hergestellte zahnprothesehaftmittel
US5087445A (en) 1989-09-08 1992-02-11 Richardson-Vicks, Inc. Photoprotection compositions having reduced dermal irritation
CA2146988A1 (en) * 1992-10-13 1994-04-28 Gideon Strassmann Treatment of cachexia and inhibition of il-6 activity
SE9402531L (sv) 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
DE69621528T2 (de) * 1995-02-07 2003-01-16 Shiseido Co. Ltd., Tokio/Tokyo Anti-inflamatorische agenzien
JPH08277224A (ja) * 1995-02-07 1996-10-22 Shiseido Co Ltd 抗炎症剤
FR2732221B1 (fr) 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
SE508760C2 (sv) * 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
BR9909801A (pt) * 1998-04-21 2002-01-22 Infectio Recherche Inc Formulações para a prevenção ou o tratamento de doenças que afetam mucosas ou pele, ou para evitar gravidez, e um aplicador para a liberação de formulações tópicas para as cavidades mucosas
WO1999064469A1 (en) * 1998-06-09 1999-12-16 Ghen Corporation FIXATION INHIBITORS FOR $i(HELICOBACTER PYLORI)
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
JP2000178196A (ja) 1998-12-11 2000-06-27 Seikagaku Kogyo Co Ltd 新規ヒアルロニダーゼ阻害剤及び外用剤
US7816402B2 (en) * 1999-03-19 2010-10-19 Bioderm, Inc. Compositions and methods for the treatment of skin
US6444647B1 (en) 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
GB9917092D0 (en) * 1999-07-22 1999-09-22 Ml Lab Plc Treatment of angiogenesis-dependent conditions
FR2799369B1 (fr) * 1999-10-08 2001-12-21 Oreal Association d'escine et de sulfate de dextran et son utilisation
US20070009586A1 (en) * 2000-02-29 2007-01-11 Cohen Kelman I Wound dressings containing complexes of transition metals and alginate for elastase sequestering
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
TWI320713B (https=) 2001-06-01 2010-02-21 Neochemir Inc
US6680062B2 (en) 2001-10-05 2004-01-20 Color Access, Inc. Anti-irritating rosacea treatment
JP2005060234A (ja) 2003-08-08 2005-03-10 Rohto Pharmaceut Co Ltd 皮膚外用剤
EP1784150A4 (en) * 2004-09-01 2011-05-11 Nexmed Holdings Inc TRANSDERMAL DELIVERY SYSTEM FOR ANTIEMETIC COMPOSITION
FR2877565A1 (fr) * 2004-11-09 2006-05-12 Oreal Utilisation d'un sulfate de dextran de haut poids moleculaire comme agent apaisant
US7384916B2 (en) * 2005-03-16 2008-06-10 Procyte Corporation Methods and compositions for preventing and treating aging or photodamaged skin
WO2006111633A2 (fr) * 2005-04-18 2006-10-26 Sc Dicophar Utilisation de la lecithine comme medicament dans le traitement du psoriasis
EP1885865A4 (en) 2005-05-12 2010-12-22 Univ North Carolina ENZYMATIC SYNTHESIS OF SULFATED POLYSACCHARIDES
GB0517236D0 (en) 2005-08-23 2005-09-28 Ricardo Uk Ltd A split carburettor with offset throttle plate
CN101282708B (zh) * 2005-10-05 2013-03-20 江崎格力高株式会社 含有磷酸化糖的皮肤外用剂
EP2069377A4 (en) 2006-09-27 2009-11-11 Univ California METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND SKIN FUNCTIONAL DISORDERS
WO2008047779A1 (fr) * 2006-10-17 2008-04-24 Glycoscience Laboratories, Inc. Agent thérapeutique ou prophylactique pour la dermatite atopique
DE102006062438A1 (de) * 2006-12-27 2008-07-03 Henkel Kgaa Kosmetische Zusammensetzungen zur Glättung und Straffung der Haut
WO2008134430A1 (en) * 2007-04-24 2008-11-06 Novelmed Therapeutics Inc. Methods and compositions of inhibiting complement and cellular activation with dextran sulfate
WO2009015183A1 (en) * 2007-07-23 2009-01-29 University Of Utah Research Foundation Method for blocking ligation of the receptor for advanced glycation end-products (rage)
US8802073B2 (en) * 2007-11-15 2014-08-12 Prelief Inc. Methods and compositions for wound healing
US8114898B2 (en) 2007-11-16 2012-02-14 Allergan, Inc. Compositions and methods for treating purpura
JP2009143863A (ja) * 2007-12-14 2009-07-02 Showa Denko Kk 皮膚収斂剤
AU2009231634B2 (en) 2008-04-04 2014-05-15 University Of Utah Research Foundation Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US7932237B2 (en) * 2008-05-15 2011-04-26 Consejo Nacional De Investigaciones Cientificas Y Technicas (CONICET) Pharmaceutical compositions for use in the treatment of wounds
EP2201930A1 (en) * 2008-12-23 2010-06-30 Intendis GmbH Hydrogel composition for the treatment of dermatological disorders
WO2010083368A2 (en) 2009-01-16 2010-07-22 Neocutis Sa Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
JO3676B1 (ar) * 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
CA2790682C (en) 2010-03-03 2020-11-24 Neocutis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds

Also Published As

Publication number Publication date
CA2790682A1 (en) 2011-09-09
US20110217249A1 (en) 2011-09-08
EP2542246A1 (en) 2013-01-09
JP2013521300A (ja) 2013-06-10
US9629856B2 (en) 2017-04-25
KR20130018739A (ko) 2013-02-25
WO2011109469A1 (en) 2011-09-09
CN102985091B (zh) 2016-11-23
CN102985091A (zh) 2013-03-20

Similar Documents

Publication Publication Date Title
CA2790682C (en) Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
AU2017218138B2 (en) Moisturizing compositions and uses thereof
RU2640504C2 (ru) Системы и композиции для послепроцедурного ухода за кожей и способы их применения
JP2013521300A5 (https=)
EP2739275B1 (fr) Composition antiseptique
BR112015020405B1 (pt) composição dermatológica antimicrobiana tópica
CN103816165A (zh) 一种治疗痤疮的组合物
JP5832302B2 (ja) ケラチンへの局所薬剤デリバリーにおける表面活性タンパク質の組成物、使用及び使用方法
DK2306999T3 (en) Compositions for the treatment of rosacea comprising chitosan and a dicarboxylsyreamid
JP6381641B2 (ja) 皮膚における外部刺激応答の鎮静化剤又は鎮静化方法
US9486397B2 (en) Dermocosmetic compositions based on a synergistic combination of colloidal silver and deoxyribonucleic acid
US20250032531A1 (en) Topically applicable preparation for enhancing the condition of skin
JPS61246130A (ja) 水性皮膚及び毛髪化粧料
HK1182951B (en) Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
HK1182951A (en) Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
RU2856885C1 (ru) Фармацевтическая композиция для лечения воспалительных заболеваний кожи
WO2012164047A1 (fr) Sucroses octasulfates de calcium, leur préparation et leurs applications pharmaceutiques et cosmétiques
WO2007080511A2 (en) Dermocosmetic composition comprising at least one antimycotic substance combined with a reepithelizing substance
HK1233528A1 (zh) 操作後的皮肤护理系统、组合物及其使用方法
HK1233528B (zh) 操作後的皮肤护理系统、组合物及其使用方法
HK1150774B (en) Compositions for treating rosacea comprising chitosan and a dicarboxylic acid amide

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160201

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD

Year of fee payment: 14

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241227

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241227

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241227

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 15TH ANNIV.) - STANDARD

Year of fee payment: 15

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260217

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260217